High-Content Analysis (HCA) or High-Content Screening (HCS) combines high-throughput automated imaging and analysis to extract quantitative multi-parametric data at the single-cell level. Originally developed as a complementary technology to traditional biochemical high-throughput screening (HTS) in drug discovery, today high-content screening is established in a far broader area of the life science space as an unbiased imaging method to assess cellular function.
High-content screening offers a number of advantages over traditional techniques:
PerkinElmer provides a range of solutions - including instruments, informatics, automation and microplates - for high content imaging and analysis, and phenotypic screening of live cells, 3D cell models, stem cells, that can be tailored by our team of experts to meet your lab’s needs.
See how the technologies behind our market-leading products help you succeed with even the most challenging applications and assays.
Discover more about how PerkinElmer high-content analysis products can advance your research in areas such as cancer, neuroscience, infectious disease, toxicity and stem cells.
Discover how PerkinElmer high-content screening solutions can benefit your research in both new and established applications.
PerkinElmer offers a range of solutions to enable you to develop your assays with ease. Find out more about the assays you are interested in and how our products can help.
Delve into our high-content resource library, for application notes, case studies and online training resources.
Read how scientists around the globe are using our high-content screening products and services to advance their research in a variety of fields, including rare genetic disease, infectious disease, cancer, and RNAi screening.
